NCT02658162View on ClinicalTrials.gov

A Study on SANGUINATE™ for the Reduction of Delayed Graft Function in Kidney Transplant Patients

PHASE2WithdrawnINTERVENTIONAL
0
Timeline

Start Date

February 29, 2016

Primary Completion Date

October 31, 2018

Study Completion Date

December 31, 2018

Conditions
Delayed Function of Renal Transplant
Interventions
DRUG

SANGUINATE

Two (2) infusions of 320 mg/kg of SANGUINATE at Baseline and Day 1

DRUG

Normal Saline

Two (2) infusions of Normal Saline at an equal volume to SANGUINATE at Baseline and Day 1.

Sponsors
All Listed Sponsors
lead

Prolong Pharmaceuticals

INDUSTRY